Exact Sciences (EXAS)Corp announced the launch of Oncodetecta-a new test designed to detect molecular residual disease, MRD, across multiple solid tumors. The Oncodetect test provides patients and ...

the MRD XL system can fully utilize its versatility and flexibility in a host-controlled fabrication environment. This makes it possible to guarantee a production or research environment free from ...